GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Market Cap

Realcan Pharmaceutical Group Co (SZSE:002589) Market Cap : ¥4,003 Mil (As of May. 22, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Realcan Pharmaceutical Group Co's share price for the quarter that ended in Mar. 2024 was ¥3.03. Realcan Pharmaceutical Group Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 1,505 Mil. Therefore, Realcan Pharmaceutical Group Co's market cap for the quarter that ended in Mar. 2024 was ¥4,559 Mil.

Realcan Pharmaceutical Group Co's quarterly market cap declined from Sep. 2023 (¥5,312 Mil) to Dec. 2023 (¥4,920 Mil) and declined from Dec. 2023 (¥4,920 Mil) to Mar. 2024 (¥4,559 Mil).

Realcan Pharmaceutical Group Co's annual market cap increased from Dec. 2021 (¥5,914 Mil) to Dec. 2022 (¥6,199 Mil) but then declined from Dec. 2022 (¥6,199 Mil) to Dec. 2023 (¥4,920 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Realcan Pharmaceutical Group Co's Enterprise Value for Today is ¥5,065 Mil.


Realcan Pharmaceutical Group Co Market Cap Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Market Cap Chart

Realcan Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,571.22 7,869.63 5,913.51 6,199.41 4,920.40

Realcan Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,928.56 5,116.01 5,311.63 4,920.40 4,559.27

Competitive Comparison of Realcan Pharmaceutical Group Co's Market Cap

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Realcan Pharmaceutical Group Co's Market Cap Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Market Cap falls into.



Realcan Pharmaceutical Group Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Realcan Pharmaceutical Group Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥3.27*1504.71
=¥4,920

Realcan Pharmaceutical Group Co's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=¥3.03*1504.71
=¥4,559

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Realcan Pharmaceutical Group Co  (SZSE:002589) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Realcan Pharmaceutical Group Co Market Cap Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Traded in Other Exchanges
N/A
Address
No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004
Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines